Valuation: Solventum Corporation

Market Cap 15.36B 13.78B 12.59B 11.49B 21.65B 1,444B 22.34B 152B 60.52B 770B 57.66B 56.42B 2,432B P/E 2026 *
61.2x
P/E 2027 * 22.4x
Enterprise Value 20.24B 18.15B 16.59B 15.14B 28.53B 1,902B 29.43B 200B 79.73B 1,015B 75.96B 74.33B 3,204B EV / Sales 2026 *
2.45x
EV / Sales 2027 * 2.3x
Free-Float
82.21%
Yield 2026 *
-
Yield 2027 * -
1 day+3.67%
1 week+11.13%
Current month+11.13%
1 month+3.84%
3 months+8.94%
6 months+27.31%
Current year+14.06%
1 week 81.66
Extreme 81.66
93.1
1 month 80.76
Extreme 80.76
93.1
Current year 62.38
Extreme 62.38
94.16
1 year 62.38
Extreme 62.38
94.16
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Exercice

Chief Executive Officer

160,990 0.0930%
17/08/26 Free

Controller/Auditor

6,911 0.0040%
15/05/26 Free

Director

3,300 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%+11.13%+36.36% - 15.36B
-3.23%+3.51%-12.02%+15.72% 190B
-2.90%+5.45%+13.04%+38.65% 125B
-2.75%+11.65%-7.90%+17.71% 124B
+0.96%+5.15%-38.02%+12.24% 99.31B
-1.80%+0.82%-7.41%+69.42% 63.65B
-0.78%+7.07%+19.44%-18.22% 57.71B
+0.79%+22.65%-5.28%+59.81% 53.26B
-6.98%-14.56%-12.60%+42.69% 47.03B
-2.36%+3.72%+3.27%-8.07% 36.15B
Average -1.54%+5.85%-1.11%+25.55% 81.15B
Weighted average by Cap. -2.09%+5.81%-6.12%+24.48%

Financials

2026 *2027 *
Net sales 8.25B 7.4B 6.76B 6.17B 11.63B 775B 11.99B 81.48B 32.49B 414B 30.96B 30.29B 1,306B 8.53B 7.65B 6.99B 6.38B 12.03B 802B 12.41B 84.29B 33.61B 428B 32.02B 31.34B 1,351B
Net income 260M 233M 213M 194M 366M 24.42B 378M 2.57B 1.02B 13.03B 975M 954M 41.13B 697M 625M 571M 521M 982M 65.5B 1.01B 6.88B 2.75B 34.95B 2.62B 2.56B 110B
Net Debt 4.88B 4.37B 4B 3.65B 6.88B 458B 7.09B 48.18B 19.21B 245B 18.31B 17.91B 772B 4.27B 3.83B 3.5B 3.2B 6.03B 402B 6.22B 42.23B 16.84B 214B 16.04B 15.7B 677B
Projected Income Statement - Annual - Solventum Corporation
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by group of products as follows: - medical instruments and accessories (57.9%): for wound care, sterilization, surgery, etc.; - medical information systems (16.3%): primarily software solutions for documentation, billing, coding, data visualization, etc. in hospital settings; - dental and orthodontic instruments and accessories (16.2%): for dental care and restoration; - purification and filtration instruments (6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (3.6%). The United States accounts for 56.1% of net sales.
Employees
20,584
Date Price Change Volume
06/11/26 $90.38 +3.67% 3,168,925
05/11/26 $87.18 -2.43% 1,880,738
04/11/26 $89.35 +5.42% 2,168,017
03/11/26 $84.76 +0.01% 1,006,233
02/11/26 $84.75 +4.21% 1,242,847
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Solventum Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
90.38USD
Average target price
96.92USD
Spread / Average Target
+7.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Solventum Corporation
  1. Stock Market
  2. Stocks
  3. SOLV Stock